Arthur Rouill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arthur rouill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arthur Rouill Today - Breaking & Trending Today

Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences ....

United States , New York , Arthur Rouill , Sonia Quaratino , Henry Wheeler , French Financial Markets Authority , Exchange Commission , Goldman Sachs , Company Annual Report On Form , Regulatory News , Euronext Paris , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Yannis Morel , Chief Operating Officer , Arvind Sood , Global Healthcare Conference , Annual Global Healthcare Conference , Annual Immune Cell Engager Virtual Conference , European Healthcare Summit Lyon , Engager Therapeutics , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document ,

TME Pharma N.V.: TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders

Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment ....

United States , France General , Noord Holland , Merck Keytruda , Arthur Rouill , Guillaume Van Renterghem , Lee Schalop , Pharmanv Euronext , Aram Mangasarian , Merck Sharp Dohme Corp , College Of Arts , University Wharton School , Vagelos Program In Life Sciences , Albert Einstein College Of Medicine , Morgan Stanley , Articles Of Association , University Of Pennsylvania , Freshfields Bruckhaus Deringer , Credit Suisse , Board Observer At Chimerix Inc , Regulatory News , Euronext Growth Paris , Corporate Governance , New York , Chief Executive Officer , Oncoceutic Chief Operating Officer ,

ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company's Share Capital

Article L233-8-II of the French Commercial Code Article 223-16 of the General Regulations of the AMF (French Financial Markets Authority) Regulatory News: ABIONYX Pharma (Paris:ABNX): Market: ....

Nicolas Fossiez , Louis Victor Delouvrier , Arthur Rouill , French Financial Markets Authority , French Commercial Code , General Regulations , Euronext Paris , Victor Delouvrier , Ihr Portfolio ,

Innate Pharma SA: Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting

Top line results of TELLOMAK Phase 2 trial in mycosis fungoides confirming promising clinical activity of lacutamab Two posters on IPH6501, Innate's second generation ANKET, for the treatment ....

United States , Pierluigi Porcu , Henry Wheeler , Charu Aggarwal , Olivier Demaria , Arthur Rouill , Lorenzo Falchi , Hirva Mamdani , American Society Of Clinical Oncology , Exchange Commission , French Financial Markets Authority , Hoosier Cancer Research Network , Company Annual Report On Form , B Cell Non Hodgkin , Euronext Paris , American Society , Clinical Oncology , Poster Session , Hematologic Malignancies Lymphoma , Chronic Lymphocytic Leukemia , Monday June , Multicenter Trial Investigating , Preliminary Antineoplastic Activity , Patients With Relapsed , Non Hodgkin Lymphoma , Lung Cancer Non Small Cell ,

Innate Pharma SA: Outcome of Innate Pharma's 2024 Annual General Meeting

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced the voting results of its shareholders at the Annual General Meeting ("AGM"), which took ....

Arthur Rouill , Henry Wheeler , Exchange Commission , French Financial Markets Authority , Company Annual Report On Form , Regulatory News , Euronext Paris , Annual General Meeting , Supervisory Board , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report , Ihr Portfolio ,